(Press-News.org) (MEMPHIS, Tenn. - DECEMBER 18, 2014) A study led by St. Jude Children's Research Hospital scientists has identified the population of white blood cells that tumors use to enhance growth and suppress the disease-fighting immune system. The results, which appear in the December 18 edition of the scientific journal Immunity, mark a turning point in cancer immunology and provide the foundation for developing more effective immunotherapies.
For years, researchers have known that a diverse group of white blood cells called myeloid-derived suppressor cells (MDSC) are more abundant in cancer patients than in healthy individuals. The cells enhance cancer growth and suppress the specialized T cells that target and destroy tumor cells. MDSCs have a common origin in the bone marrow, but leave to travel throughout the body and become immune cells with different functions. Blocking T cells is one of the main MDSC functions.
Until now, however, efforts to distinguish among the cell types and identify the population responsible for anti-tumor immune suppression have fallen short. The puzzle has hampered efforts to harness the immune system to fight disease.
Working in the laboratory and in mouse models of cancer, researchers on this study showed immune suppression associated with MDSCs is primarily the work of a type of white blood cells called monocytes. Monocytes give rise to macrophages that help clean up dead or damaged tissue, fight cancer and regulate the immune response.
"We have identified the monocytic cells as the important cell to target, not only in cancer but possibly for treatment of autoimmune disorders like rheumatoid arthritis or inflammatory bowel diseases where dampening the immune response could provide relief," said corresponding author Peter Murray, Ph.D., a member of the St. Jude departments of Infectious Diseases and Immunology. "We also identified growth factors and other molecules essential to the survival and function of these monocytic cells. Targeting these molecules could lead to more precise approaches for controlling the immune response at the tumor site.
"This study marks a significant step in efforts to understand, develop and optimize immunotherapies for treatment of cancer," he said.
Murray's interest in MDSCs dates to 2008 and coincided with research from other St. Jude investigators. Their studies provided insight into regulation of two forms of programmed cell-death pathways known as apoptosis and necroptosis. Cells use the pathways to get rid of damaged, dangerous or unneeded cells.
From the laboratory of co-author Joseph Opferman, Ph.D., an associate member of the St. Jude Department of Cell and Molecular Biology, came evidence that switching off the MCL1 gene in bone marrow led to the death of granulocytes, but not monocytes, via apoptosis. Then work from Douglas Green, Ph.D., chair of the St. Jude Department of Immunology, highlighted the protein FLIP as a key regulator of both apoptosis and necroptosis. Selectively eliminating FLIP in mice resulted in an over-abundance of granulocytes and a reduction in monocytes and related cells.
In this study, researchers selectively eliminated MCL1 or FLIP to track how the loss of granulocytes or monocytes affected T cells in the laboratory and in mouse models of neuroblastoma and other cancers. The results showed that monocytic cells are primarily responsible for T cell suppression around tumors. Scientists are still determining the role of the granulocytes in tumors.
"We've known for decades that cancer has harnessed the immune system to keep pumping out large numbers of mature and immature myeloid cells from the bone marrow," Murray said. "Collaborating with the Opferman and Green laboratories gave us the tools we need to discriminate between the cell populations and identify monocytic cells as the important cells to target with immunotherapies."
The work also provided new details of how FLIP, MCL1 and the MCL1-like protein A1 work together to ensure survival of the monocytic population of MDSCs. For example, FLIP blocks programmed cell death via apoptosis and necrosis, but researchers showed that survival of monocytic cells required inhibition of just the apoptotic pathway. Investigators also identified the growth factor that regulates production of A1, which in the absence of MCL1 can block the death of monocytes by blocking one of the cell death pathways.
INFORMATION:
The first author is Jessica Haverkamp, Ph.D., a postdoctoral fellow in Murray's laboratory. The other authors are Amber Smith, Ricardo Weinlich, Christopher Dillon, Geoffrey Neale and Brian Koss, all of St. Jude; Joseph Qualls, formerly of St. Jude; Young Kim, Johns Hopkins School of Medicine, Baltimore; Vincenzo Bronte, Verona University Hospital and Department of Pathology, Verona, Italy; and Marco Herold, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.
The research was funded in part by the Hartwell Foundation, Alex's Lemonade Stand Foundation, a grant (CA21765) from the National Cancer Institute at the National Institutes of Health and ALSAC.
St. Jude Media Relations Contacts
Carrie Strehlau
desk (901) 595-2295
cell (901) 297-9875
carrie.strehlau@stjude.org
Summer Freeman
desk (901) 595-3061
cell (901) 297-9861
summer.freeman@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food--because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude at @stjuderesearch.
In a previous randomized controlled trial, Stanford University researchers developed two curricula for Girl Scouts to use energy more efficiently: one on energy use at home, and the other in transportation and food. Both courses were effective for girls in the short term, and the home energy course was effective for girls in the long term and for parents in the short term.
Subsequently, the Northern California Girl Scouts began disseminating the programs via manuals and reusable materials, but that method of disseminating the programs has not lead to widespread use.
On ...
[Boston, MA December18, 2014] Parents of children involved in an elementary school-based community intervention to prevent obesity appear to share in its health benefits. A new analysis of Shape Up Somerville: Eat Smart Play Hard™ shows an association between being exposed to the intervention as a parent and a modest decrease in body mass index (BMI) compared to parents in two similar control communities. The study led by researchers at the Friedman School of Nutrition Science and Policy at Tufts University and the Centers for Disease Control and Prevention (CDC) ...
University of Chicago developmental neuroscientists have found specific brain markers that predict generosity in children. Those neural markers appear to be linked to both social and moral evaluation processes.
There are many sorts of prosocial behaviors. Although young children are natural helpers, their perspective on sharing resources tends to be selfish. Jean Decety, the Irving B. Harris Professor of Psychology and Psychiatry, and Jason Cowell, a postdoctoral scholar in Decety's Child NeuroSuite lab, wanted to find out how young children's brains evaluate whether ...
Australian scientists have developed a model for oil palm cultivation, aimed at helping growers of the crop maximize the yields of their plantations, while minimizing detrimental environmental impacts.
The model was recently published in the journal Environmental Modeling & Software.
"Oil palm has become a major crop in the tropics, cultivated on more than 39 million acres of land," co-author Dr Paul Nelson of James Cook University (JCU) said.
"Demand for the product continues to grow, and the industry is expected to keep expanding in the foreseeable future.
"At ...
Scientists at A*STAR's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IMCB) have identified a genetic pathway that accounts for the extraordinary size of the human brain. The team led by Dr Bruno Reversade from A*STAR in Singapore, together with collaborators from Harvard Medical School, have identified a gene, KATNB1, as an essential component in a genetic pathway responsible for central nervous system development in humans and other animals.
By sequencing the genome of individuals of normal height but with a very small head size, ...
Here's a nice surprise: quantum physics is less complicated than we thought. An international team of researchers has proved that two peculiar features of the quantum world previously considered distinct are different manifestations of the same thing. The result is published 19 December in Nature Communications.
Patrick Coles, Jedrzej Kaniewski, and Stephanie Wehner made the breakthrough while at the Centre for Quantum Technologies at the National University of Singapore. They found that 'wave-particle duality' is simply the quantum 'uncertainty principle' in disguise, ...
Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
The research, led by Dr Claire Gillan and Professor Trevor Robbins (Department of Psychology) is the latest in a series of studies from the Cambridge Behavioural and Clinical Neuroscience Institute investigating the possibility that compulsions in OCD are products of an overactive habit-system. This line of work has shifted opinion away from thinking of OCD as ...
The memory and walking speeds of adults who have lost all of their teeth decline more rapidly than in those who still have some of their own teeth, finds new UCL research.
The study, published in the Journal of the American Geriatrics Society, looked at 3,166 adults aged 60 or over from the English Longitudinal Study of Ageing (ELSA) and compared their performance in tests of memory and walking speed. The results showed that the people with none of their own teeth performed approximately 10% worse in both memory and walking speed tests than the people with teeth.
The ...
Hormone replacement therapy (HRT) is the most effective treatment for menopausal symptoms, in particular for younger women at the onset of the menopause, suggests a new review published today (19 December) in The Obstetrician & Gynaecologist (TOG).
The review highlights that menopausal symptoms, including hot flushes and night sweats are common, affecting around 70% of women for an average of 5 years but may continue for many years in about 10% of women.
Every woman experiences the menopause differently; some experience one or two symptoms mildly while others have ...
Less than half of UK prescriptions for antipsychotic drugs are being issued to treat the serious mental illnesses for which they are mainly licensed, reveals research published in the online journal BMJ Open.
Instead, they may often be prescribed 'off label' to older people with other conditions, such as anxiety and dementia, despite the greater risk of potentially serious side effects in this age group, the findings indicate.
The researchers analysed family doctors' prescribing patterns for first and second generation antipsychotic drugs across the UK between 2007 ...
